Expand SYRE Menu
SYRE MENU

SYRE Latest Press Releases

-- March 16, 2026 --

Spyre Announces Acceleration of Expected Topline Readout of SKYWAY Rheumatoid Arthritis Sub-study to Q3 2026 Globe Newswire 8:00 AM

-- March 6, 2026 --

Spyre Therapeutics Announces Grants of Inducement Awards Globe Newswire 4:05 PM

-- February 24, 2026 --

Spyre Therapeutics to Participate in Upcoming March Investor Conferences Globe Newswire 4:05 PM

-- February 19, 2026 --

Spyre Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update Globe Newswire 4:02 PM

-- February 18, 2026 --

Spyre Therapeutics Announces Presentations at the 21st ECCO Congress Supporting Differentiated Profile of SPY003 and Novel Animal Studies Demonstrating Superiority of Combination Approach Globe Newswire 8:00 AM

-- February 6, 2026 --

Spyre Therapeutics Announces Grants of Inducement Awards Globe Newswire 4:01 PM

-- January 23, 2026 --

Spyre Therapeutics Announces Grants of Inducement Awards Globe Newswire 4:00 PM

-- January 12, 2026 --

Spyre Therapeutics Poised for Transformational 2026 With Six Expected Proof-of-Concept Readouts Beginning in Q2 Globe Newswire 8:00 AM

-- January 8, 2026 --

Spyre Therapeutics Announces Grants of Inducement Awards Globe Newswire 4:05 PM

-- December 5, 2025 --

Spyre Therapeutics Announces Grants of Inducement Awards Globe Newswire 4:05 PM

-- November 7, 2025 --

Spyre Therapeutics Announces Grants of Inducement Awards Globe Newswire 4:05 PM

-- November 4, 2025 --

Spyre Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update Globe Newswire 4:05 PM
Spyre Therapeutics Announces Positive Interim Phase 1 Results for SPY003, Its Novel, Half-Life Extended anti-IL-23 Antibody Globe Newswire 4:01 PM

-- October 29, 2025 --

Spyre Therapeutics to Participate in Upcoming November Investor Conferences Globe Newswire 4:05 PM

-- October 24, 2025 --

Spyre Therapeutics Announces Poster Presentations at American College of Rheumatology (ACR) Convergence 2025 Globe Newswire 8:00 AM
Market Data Delayed 15 Minutes